Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Naloxon

USA. FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose

USA. FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose

Agency Continues to Support Development of Overdose Reversal Drugs including Naloxone and Nalmefene. (FDA – Federal Drug Administation, USA, 08.07.2024)

https://www.fda.gov/news-events/press-announcements/fda-approves-first-nalmefene-hydrochloride-auto-injector-reverse-opioid-overdose